These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12517586)

  • 1. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation.
    Maeda T; Yoshimura T; Okamura H
    J Soc Gynecol Investig; 2003 Jan; 10(1):2-4. PubMed ID: 12517586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, in umbilical blood.
    Tsukahara H; Ohta N; Tokuriki S; Nishijima K; Kotsuji F; Kawakami H; Ohta N; Sekine K; Nagasaka H; Mayumi M
    Metabolism; 2008 Feb; 57(2):215-20. PubMed ID: 18191051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma asymmetric dimethylarginine concentration during the perinatal period.
    Vida G; Sulyok E; Ertl T; Martens-Lobenhoffer J; Bode-Boger SM
    Neonatology; 2007; 92(1):8-13. PubMed ID: 17596731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical vein plasma concentrations of asymmetrical dimethylarginine are increased in male but not female neonates delivered preterm: a pilot study.
    Mittermayer F; Prusa AR; Pollak A; Wolzt M
    Early Hum Dev; 2006 Jul; 82(7):421-4. PubMed ID: 16364572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia.
    Holden DP; Fickling SA; Whitley GS; Nussey SS
    Am J Obstet Gynecol; 1998 Mar; 178(3):551-6. PubMed ID: 9539525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
    Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
    Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia.
    Chedraui P; Solis EJ; Bocci G; Gopal S; Russo E; Escobar GS; Hidalgo L; Pérez-López FR; Genazzani AR; Mannella P; Simoncini T
    J Matern Fetal Neonatal Med; 2013 Feb; 26(3):226-32. PubMed ID: 23039092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia.
    Braekke K; Ueland PM; Harsem NK; Staff AC
    Pediatr Res; 2009 Oct; 66(4):411-5. PubMed ID: 19581842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC.
    Teerlink T
    Methods Mol Med; 2005; 108():263-74. PubMed ID: 16028689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine.
    Prefumo F; Thilaganathan B; Whitley GS
    Ultrasound Obstet Gynecol; 2008 Feb; 31(2):153-7. PubMed ID: 18254158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans.
    Kielstein JT; Impraim B; Simmel S; Bode-Böger SM; Tsikas D; Frölich JC; Hoeper MM; Haller H; Fliser D
    Circulation; 2004 Jan; 109(2):172-7. PubMed ID: 14662708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients.
    Hermenegildo C; Medina P; Peiró M; Segarra G; Vila JM; Ortega J; Lluch S
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5636-40. PubMed ID: 12466365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
    Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects.
    Schulze F; Maas R; Freese R; Schwedhelm E; Silberhorn E; Böger RH
    Eur J Clin Invest; 2005 Oct; 35(10):622-6. PubMed ID: 16178881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
    Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse correlation between maternal plasma asymmetric dimethylarginine (ADMA) and birthweight percentile in women with impaired placental perfusion: circulating ADMA as an NO-independent indicator of fetal growth restriction?
    Tsikas D; Bollenbach A; Savvidou MD
    Amino Acids; 2018 Feb; 50(2):341-351. PubMed ID: 29235018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis.
    Landburg PP; Teerlink T; Muskiet FA; Duits AJ; Schnog JJ;
    Am J Hematol; 2008 Jul; 83(7):577-9. PubMed ID: 18383318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.